Approval was based on results from the Phase IIIb TRAILBLAZER-ALZ 6 trial, which showed that Kisunla achieved comparable ...

Alzheimer’s and brain health deserve attention year-round, as millions are affected by dementia and related conditions.

Microglia replacement therapy helps treat people with a rare genetic condition called ALSP, suggesting the approach could ...

Scientists at UCSF combined advanced brain-network modeling, genetics, and imaging to reveal how tau protein travels through ...

Following a Mediterranean diet long-term may have weight loss benefits but it may not be enough to enhance cognitive function ...

The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...

Recognizing the five critical signs of Alzheimer's final progression helps families understand what to expect and how to ...

Previous studies have concluded that early intervention in dementia cases can increase patients' treatment options and ...

A recent review by researchers at Philadelphia College of Osteopathic Medicine (PCOM) shows Chlamydia pneumoniae (Cpn) and ...

Study offers patients the opportunity to try an experimental, non-drug therapy for Alzheimer's using an FDA-designated Breakthrough Device ATLANTA, July ...

Alzheimer’s disease is a serious condition that causes memory loss and thinking problems. While there’s no cure, research ...

A recent study from UCLA identifies four distinct clusters of symptoms that can progress to Alzheimer's disease, offering new ...